470 related articles for article (PubMed ID: 18367106)
21. [Proliferative activity of stage I testicular neoplasms: evaluation by image analysis of immunoreactive MIB-1].
Martinazzi M; Zampieri A; Martinazzi S; Crivelli F; Mauri MF; Calandra C
Pathologica; 1998 Dec; 90(6):783-7. PubMed ID: 10220999
[TBL] [Abstract][Full Text] [Related]
22. The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
Marwaha S; Venner PM; North SA
Can J Urol; 2007 Oct; 14(5):3692-6. PubMed ID: 17949524
[TBL] [Abstract][Full Text] [Related]
23. The Significance of Spermatic Cord Involvement by Testicular Germ Cell Tumors: Should We Be Staging Discontinuous Invasion From Involved Lymphovascular Spaces Differently From Direct Extension?
Sanfrancesco JM; Trevino KE; Xu H; Ulbright TM; Idrees MT
Am J Surg Pathol; 2018 Mar; 42(3):306-311. PubMed ID: 29309304
[TBL] [Abstract][Full Text] [Related]
24. Positive expressions of N-acetylglucosaminyltransferase-V (GnT-V) and beta1-6 branching N-linked oligosaccharides in human testicular germ cells diminish during malignant transformation and progression.
Kyan A; Kamimura N; Hagisawa S; Hatakeyama S; Koie T; Yoneyama T; Arai Y; Nakagawa H; Nishimura S; Miyoshi E; Hashimoto Y; Ohyama C
Int J Oncol; 2008 Jan; 32(1):129-34. PubMed ID: 18097551
[TBL] [Abstract][Full Text] [Related]
25. Association of intratubular seminoma and intratubular embryonal carcinoma with invasive testicular germ cell tumors.
Lau SK; Weiss LM; Chu PG
Am J Surg Pathol; 2007 Jul; 31(7):1045-9. PubMed ID: 17592271
[TBL] [Abstract][Full Text] [Related]
26. What does the pathology report really mean?
Ro JY; Amato RJ; Ayala AG
Semin Urol Oncol; 1996 Feb; 14(1):2-7. PubMed ID: 9132264
[TBL] [Abstract][Full Text] [Related]
27. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis.
Looijenga LH; Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW
Ann N Y Acad Sci; 2007 Dec; 1120():187-214. PubMed ID: 17911410
[TBL] [Abstract][Full Text] [Related]
28. Survival of metastatic germ cell cancer patients assessed by international germ cell consensus classification in Japan.
Shintaku I; Satoh M; Okajima E; Fujimoto H; Kamoto T; Ogawa O; Kawai K; Akaza H; Tsukamoto T; Naito S; Miki T; Arai Y
Jpn J Clin Oncol; 2008 Apr; 38(4):281-7. PubMed ID: 18321891
[TBL] [Abstract][Full Text] [Related]
29. Late relapse of testicular germ cell tumors.
Carver BS; Motzer RJ; Kondagunta GV; Sogani PG; Sheinfeld J
Urol Oncol; 2005; 23(6):441-5. PubMed ID: 16301125
[TBL] [Abstract][Full Text] [Related]
30. Current management of stage I testicular non-seminomatous germ cell tumours.
Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Kawai T; Tanaka Y;
Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological study of regressed testicular tumors (apparent extragonadal germ cell neoplasms).
Angulo JC; González J; Rodríguez N; Hernández E; Núñez C; Rodríguez-Barbero JM; Santana A; López JI
J Urol; 2009 Nov; 182(5):2303-10. PubMed ID: 19762049
[TBL] [Abstract][Full Text] [Related]
33. [Treatment decision in advanced testicular germ cell tumors].
Salazar Soler R; Montesinos Muñoz J; Maroto Rey P; Villavicencio Mavrich H
Arch Esp Urol; 2000; 53(6):522-33. PubMed ID: 11002521
[TBL] [Abstract][Full Text] [Related]
34. Late recurrence in 1263 men with testicular germ cell tumors. Multivariate analysis of risk factors and implications for management.
Shahidi M; Norman AR; Dearnaley DP; Nicholls J; Horwich A; Huddart RA
Cancer; 2002 Aug; 95(3):520-30. PubMed ID: 12209744
[TBL] [Abstract][Full Text] [Related]
35. Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.
Saju SV; Radhakrishnan V; Ganesan TS; Dhanushkodi M; Raja A; Selvaluxmy G; Sagar TG
Med Oncol; 2019 Feb; 36(3):28. PubMed ID: 30725328
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment of urological malignancy: the testes.
Wilkins M; Horwich A
Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):199-203. PubMed ID: 8777501
[TBL] [Abstract][Full Text] [Related]
37. Management of clinical stage I nonseminomatous germ-cell testis tumors.
Flechon A; Droz JP
Expert Rev Anticancer Ther; 2003 Feb; 3(1):21-30. PubMed ID: 12597346
[TBL] [Abstract][Full Text] [Related]
38. Tumor markers in testicular germ cell tumors related to the stage of the disease at the time of diagnosis.
Jacobsen GK
Oncodev Biol Med; 1983; 4(6):C39-44. PubMed ID: 6196749
[TBL] [Abstract][Full Text] [Related]
39. Guidelines on testicular cancer.
Albers P; Albrecht W; Algaba F; Bokemeyer C; Cohn-Cedermark G; Horwich A; Klepp O; Laguna MP; Pizzocaro G
Eur Urol; 2005 Dec; 48(6):885-94. PubMed ID: 16126333
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of male seminomatous and nonseminomatous germ cell tumors and response to first-line chemotherapy from a tertiary cancer center in India.
Joshi A; Zanwar S; Shetty N; Patil V; Noronha V; Bakshi G; Prakash G; Menon S; Prabhash K
Indian J Cancer; 2016; 53(2):313-316. PubMed ID: 28071636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
